Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy

Table 3 Summary of exclusions in the analyses of COMPLY patients

	Placebo	Bolus	Bolus + infusion
Patients with available CK-MB values^a	307	303	311
Excluded patients
<5 points	23	23	25
No infarct	6	8	8
Could not fit	0	1	1
Delayed infarct	2	2	2
Second infarct	4	5	5
Final sample size for CK-MB analysis	272	264	270

CK, creatine kinase; COMPLY, COMPlement inhibition in myocardial infarction treated with thromboLYtics. ^aPatients with at least 5 serial CK-MB measures.

ISSN: 1745-6215